Table 3.
Measures | df | F | Significance |
---|---|---|---|
Disability | |||
Session 1 vs B | 1,10 | 1.502 | 0.248 |
Session 2 vs B | 0.291 | 0.601 | |
Session 3 vs B | 3.997 | 0.073 | |
Session 4 vs B | 11.175 | 0.007 | |
Session 5 vs B | 6.582 | 0.028 | |
Session 6 vs B | 17.189 | 0.002 | |
Session 7 vs B | 12.395 | 0.006 | |
Session 8 vs B | 25.664 | 0.000 | |
McGill Pain | |||
Session 1 vs B | 1,10 | 0.000 | 0.990 |
Session 2 vs B | 0.008 | 0.930 | |
Session 3 vs B | 0.447 | 0.519 | |
Session 4 vs B | 11.364 | 0.007 | |
Session 5 vs B | 3.850 | 0.078 | |
Session 6 vs B | 9.200 | 0.013 | |
Session 7 vs B | 9.097 | 0.013 | |
Session 8 vs B | 12.030 | 0.006 | |
Catastrophizing | |||
Session 1 vs B | 1,10 | 2.883 | 0.120 |
Session 2 vs B | 0.052 | 0.825 | |
Session 3 vs B | 2.918 | 0.118 | |
Session 4 vs B | 5.657 | 0.039 | |
Session 5 vs B | 10.918 | 0.008 | |
Session 6 vs B | 13.012 | 0.005 | |
Session 7 vs B | 16.576 | 0.002 | |
Session 8 vs B | 22.774 | 0.001 |
df: degree of freedom; B: baseline assessment; Disability: Pain Disability Index (PDI); McGill Pain: McGill pain questionnaire (SF-MPQ); Catastrophizing: Pain Catastrophizing Scale (PCS); BOLD: significant finding.